Polina German

3.5k total citations
36 papers, 1.9k citations indexed

About

Polina German is a scholar working on Infectious Diseases, Hepatology and Epidemiology. According to data from OpenAlex, Polina German has authored 36 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 12 papers in Hepatology and 9 papers in Epidemiology. Recurrent topics in Polina German's work include HIV/AIDS drug development and treatment (16 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (5 papers). Polina German is often cited by papers focused on HIV/AIDS drug development and treatment (16 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (5 papers). Polina German collaborates with scholars based in United States, United Kingdom and Thailand. Polina German's co-authors include Anita Mathias, Brian P. Kearney, Francesca Aweeka, Diana M. Brainard, James Hoi Po Hui, David R. Warren, Steve West, John Ling, S. Ramanathan and Rita Humeniuk and has published in prestigious journals such as Journal of the American College of Cardiology, Hepatology and Analytical Biochemistry.

In The Last Decade

Polina German

34 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Polina German United States 20 905 425 424 377 280 36 1.9k
Darius Babusis United States 21 1.8k 2.0× 462 1.1× 276 0.7× 549 1.5× 208 0.7× 45 2.8k
Anita Mathias United States 27 1.4k 1.5× 708 1.7× 700 1.7× 290 0.8× 504 1.8× 65 2.6k
Edward O’Mara United States 21 668 0.7× 505 1.2× 247 0.6× 155 0.4× 268 1.0× 46 1.6k
Caroline Solas France 23 920 1.0× 258 0.6× 246 0.6× 212 0.6× 208 0.7× 94 1.5k
Rob ter Heine Netherlands 26 727 0.8× 309 0.7× 69 0.2× 266 0.7× 453 1.6× 163 2.2k
Larissa Wenning United States 27 1.9k 2.1× 448 1.1× 314 0.7× 560 1.5× 279 1.0× 71 2.9k
Lorena Baietto Italy 27 826 0.9× 349 0.8× 227 0.5× 233 0.6× 182 0.7× 61 1.6k
Julie Borland United States 26 1.3k 1.4× 339 0.8× 111 0.3× 309 0.8× 154 0.6× 52 2.0k
Hartwig Klinker Germany 31 1.1k 1.2× 1.6k 3.9× 1.3k 3.1× 279 0.7× 207 0.7× 157 2.9k
Gabriel Birkuš United States 23 1.2k 1.3× 577 1.4× 194 0.5× 572 1.5× 203 0.7× 41 1.9k

Countries citing papers authored by Polina German

Since Specialization
Citations

This map shows the geographic impact of Polina German's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Polina German with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Polina German more than expected).

Fields of papers citing papers by Polina German

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Polina German. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Polina German. The network helps show where Polina German may publish in the future.

Co-authorship network of co-authors of Polina German

This figure shows the co-authorship network connecting the top 25 collaborators of Polina German. A scholar is included among the top collaborators of Polina German based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Polina German. Polina German is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaski, Juan Pablo, Paul F. Kantor, Stephanie J. Nakano, et al.. (2025). Efficacy and Safety of Aficamten in Children and Adolescents With Obstructive Hypertrophic Cardiomyopathy: Study Design and Rationale of CEDAR-HCM. Circulation Heart Failure. 19(2). e013418–e013418.
2.
Simkins, Tyrell, Jianlin Li, Priyanka Solanki, et al.. (2025). EVALUATION OF CYTOCHROME P450 2C9, 2C19, AND 2D6 INHIBITION ON THE PHARMACOKINETICS OF AFICAMTEN IN HEALTHY PARTICIPANTS. Journal of the American College of Cardiology. 85(12). 1428–1428.
3.
Xu, Donghong, Justin D. Lutz, Jianlin Li, et al.. (2025). Effect of Hepatic Impairment or Renal Impairment on the Pharmacokinetics of Aficamten. Clinical Pharmacokinetics. 64(3). 397–406. 2 indexed citations
4.
Xu, Donghong, et al.. (2024). Pharmacokinetics, disposition, and biotransformation of the cardiac myosin inhibitor aficamten in humans. Pharmacology Research & Perspectives. 12(5). e70006–e70006. 6 indexed citations
5.
Humeniuk, Rita, Anita Mathias, Brian J. Kirby, et al.. (2021). Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor. Clinical Pharmacokinetics. 60(5). 569–583. 93 indexed citations
6.
Xiao, Deqing, Kah Hiing John Ling, Thomas Tarnowski, et al.. (2021). Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies. Analytical Biochemistry. 617. 114118–114118. 43 indexed citations
7.
8.
German, Polina, Anita Mathias, Diana M. Brainard, & Brian P. Kearney. (2018). Drug–Drug Interaction Profile of the Fixed-Dose Combination Tablet Regimen Ledipasvir/Sofosbuvir. Clinical Pharmacokinetics. 57(11). 1369–1383. 11 indexed citations
9.
Garrison, Kimberly L., Polina German, Erik Mogalian, & Anita Mathias. (2018). The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection. Drug Metabolism and Disposition. 46(8). 1212–1225. 51 indexed citations
10.
Mogalian, Erik, Polina German, Brian P. Kearney, et al.. (2015). Use of Multiple Probes to Assess Transporter- and Cytochrome P450-Mediated Drug–Drug Interaction Potential of the Pangenotypic HCV NS5A Inhibitor Velpatasvir. Clinical Pharmacokinetics. 55(5). 605–613. 41 indexed citations
11.
Zhou, Lijun, Xian-De Liu, Mingli Sun, et al.. (2015). Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma. Oncogene. 35(21). 2687–2697. 301 indexed citations
12.
Gao, Meng, Jingdan Liang, Yongling Lu, et al.. (2013). Site-specific activation of AKT protects cells from death induced by glucose deprivation. Oncogene. 33(6). 745–755. 54 indexed citations
13.
German, Polina, Hui C. Liu, Javier Szwarcberg, et al.. (2012). Effect of Cobicistat on Glomerular Filtration Rate in Subjects With Normal and Impaired Renal Function. JAIDS Journal of Acquired Immune Deficiency Syndromes. 61(1). 32–40. 133 indexed citations
14.
Lawitz, E.J., Jacqueline Hill, Lydie Hazan, et al.. (2012). 1188 GS-6620, A LIVER-TARGETED NUCLEOTIDE PRODRUG, EXHIBITS ANTIVIRAL ACTIVITY AND FAVORABLE SAFETY PROFILE OVER 5 DAYS IN TREATMENT NAIVE CHRONIC HCV GENOTYPE 1 SUBJECTS. Journal of Hepatology. 56. S470–S471. 7 indexed citations
15.
Ramanathan, S., Anita Mathias, Polina German, & Brian P. Kearney. (2011). Clinical Pharmacokinetic and Pharmacodynamic Profile of the HIV Integrase Inhibitor Elvitegravir. Clinical Pharmacokinetics. 50(4). 229–244. 127 indexed citations
16.
German, Polina, David R. Warren, Steve West, James Hoi Po Hui, & Brian P. Kearney. (2010). Pharmacokinetics and Bioavailability of an Integrase and Novel Pharmacoenhancer-Containing Single-Tablet Fixed-Dose Combination Regimen for the Treatment of HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(3). 323–329. 78 indexed citations
17.
Mathias, Anita, Polina German, Bernard P. Murray, et al.. (2009). Pharmacokinetics and Pharmacodynamics of GS-9350: A Novel Pharmacokinetic Enhancer Without Anti-HIV Activity. Clinical Pharmacology & Therapeutics. 87(3). 322–329. 171 indexed citations
18.
German, Polina, Sunil Parikh, Jody Lawrence, et al.. (2009). Lopinavir/Ritonavir Affects Pharmacokinetic Exposure of Artemether/Lumefantrine in HIV-Uninfected Healthy Volunteers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 51(4). 424–429. 68 indexed citations
19.
Mwesigwa, Julia, Sunil Parikh, Bryan McGee, et al.. (2009). Pharmacokinetics of Artemether-Lumefantrine and Artesunate-Amodiaquine in Children in Kampala, Uganda. Antimicrobial Agents and Chemotherapy. 54(1). 52–59. 66 indexed citations
20.
Aweeka, Francesca & Polina German. (2008). Clinical Pharmacology of Artemisinin-Based Combination Therapies. Clinical Pharmacokinetics. 47(2). 91–102. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Darius Babusis Breakdown of academic impact, for papers by Anita Mathias Breakdown of academic impact, for papers by Edward O’Mara Breakdown of academic impact, for papers by Caroline Solas Breakdown of academic impact, for papers by Rob ter Heine Breakdown of academic impact, for papers by Larissa Wenning Breakdown of academic impact, for papers by Lorena Baietto Breakdown of academic impact, for papers by Julie Borland Breakdown of academic impact, for papers by Hartwig Klinker Breakdown of academic impact, for papers by Gabriel Birkuš
Rankless by CCL
2026